Zelgen(SH:688266) Xin Lang Cai Jing·2025-10-16 02:30Group 1 - The core point of the news is that Zai Lab Ltd. (泽璟制药) experienced a stock price increase of 5.01%, reaching 101.78 CNY per share, with a total market capitalization of 26.942 billion CNY [1] - Zai Lab, founded on March 18, 2009, specializes in the research, production, and sales of chemical and biological new drugs, with 99.97% of its revenue coming from pharmaceuticals [1] - The trading volume for Zai Lab was 1.68 million CNY, with a turnover rate of 0.64% [1] Group 2 - According to data, a fund under Jianxin Fund holds Zai Lab as one of its top ten heavy positions, specifically Jianxin Medical Health Industry Stock A (建信医疗健康行业股票A), which reduced its holdings by 29,420 shares in the second quarter [2] - The current holding of Jianxin Medical Health Industry Stock A is 338,600 shares, accounting for 4.18% of the fund's net value, making it the sixth-largest heavy position [2] - The fund has achieved a year-to-date return of 50.69% and a one-year return of 41.08%, ranking 404 out of 4,218 and 1,255 out of 3,864 in its category, respectively [2]